Literature DB >> 18925882

Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors.

F Meiler1, S Klunker, M Zimmermann, C A Akdis, M Akdis.   

Abstract

BACKGROUND: Allergic diseases are characterized by the activation of the immune system and formation of immunoglobulin (Ig)E antibodies against normally innocuous environmental antigens, whereas IgG4 and IgA represent noninflammatory and blocking antibody isotypes. The T helper 2 (Th2) cells induce and T regulatory (Treg) cells suppress several features of allergic inflammation. Our aim was to investigate the role of allergen-specific T regulatory type 1 (Tr1) cells and CD4(+)CD25(+) Treg cells and toll-like receptors (TLRs) on IgE, IgG4 and IgA production.
METHODS: Germline or productive Ig-transcripts are determined by real-time reverse transcriptase-polymerase chain reaction, secreted Igs are measured by enzyme-linked immunosorbent assay and the frequency of Ig-producing plasma cells is investigated by enzyme-linked immunosorbent spot. Circulating CD4(+)CD25(+) Treg cells and allergen-specific Tr1 cells are used.
RESULTS: Both allergen-specific, interleukin-10-secreting Tr1 cells and CD4(+)CD25(+) Treg cells from healthy individuals induced IgG4 and suppressed IgE production in peripheral blood mononuclear cells and purified B-cell cultures. In contrast, induction of IgA production is independent of T-cell help and the role of Tr1 or Treg cells is very limited, whereas it was highly induced by direct B-cell activation via TLR7 and 9.
CONCLUSIONS: These data suggest that T regulatory cells may contribute to the suppression of allergic diseases by suppression of IgE and induction of IgG4, whereas IgA production is enhanced by B-cell activation via TLR7 and TLR9.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18925882     DOI: 10.1111/j.1398-9995.2008.01774.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  88 in total

Review 1.  The development and function of regulatory T cells.

Authors:  Creg J Workman; Andrea L Szymczak-Workman; Lauren W Collison; Meenu R Pillai; Dario A A Vignali
Journal:  Cell Mol Life Sci       Date:  2009-04-24       Impact factor: 9.261

2.  CDK4/6 inhibitor palbociclib suppresses IgE-mediated mast cell activation.

Authors:  Yi-Bo Hou; Kunmei Ji; Yue-Tong Sun; Li-Na Zhang; Jia-Jie Chen
Journal:  J Transl Med       Date:  2019-08-20       Impact factor: 5.531

3.  Esophageal IgG4 levels correlate with histopathologic and transcriptomic features in eosinophilic esophagitis.

Authors:  C E Rosenberg; M K Mingler; J M Caldwell; M H Collins; P C Fulkerson; D W Morris; V A Mukkada; P E Putnam; T Shoda; T Wen; M E Rothenberg
Journal:  Allergy       Date:  2018-06-17       Impact factor: 13.146

Review 4.  Harnessing regulatory T cells to suppress asthma: from potential to therapy.

Authors:  Alison N Thorburn; Philip M Hansbro
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-22       Impact factor: 6.914

Review 5.  T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.

Authors:  Itay Raphael; Saisha Nalawade; Todd N Eagar; Thomas G Forsthuber
Journal:  Cytokine       Date:  2014-10-30       Impact factor: 3.861

6.  Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs.

Authors:  Cezmi A Akdis; Mübeccel Akdis
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

Review 7.  IgG4-associated cholangitis: a comprehensive review.

Authors:  Lowiek M Hubers; Lucas J Maillette de Buy Wenniger; Marieke E Doorenspleet; Paul L Klarenbeek; Joanne Verheij; Erik A Rauws; Thomas M van Gulik; Ronald P J Oude Elferink; Stan F J van de Graaf; Niek de Vries; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

8.  Kimura's disease or IgG4-related disease? A case-based review.

Authors:  Lei Liu; Yong Chen; Zhi Fang; Jingping Kong; Xiudi Wu; Zhen Zhang
Journal:  Clin Rheumatol       Date:  2013-12-19       Impact factor: 2.980

Review 9.  Novel developments in the mechanisms of immune tolerance to allergens.

Authors:  Thomas Eiwegger; Saskia Gruber; Zsolt Szépfalusi; Cezmi A Akdis
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

10.  Test-based exclusion diets in gastro-esophageal reflux disease patients: a randomized controlled pilot trial.

Authors:  Michele Caselli; Giovanni Zuliani; Francesca Cassol; Nadia Fusetti; Elena Zeni; Natalina Lo Cascio; Cecilia Soavi; Sergio Gullini
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.